Follow
Ian S. Hagemann
Ian S. Hagemann
Associate Professor, Dept. of Pathology and Immunology, Washington University in St. Louis
Verified email at wustl.edu
Title
Cited by
Cited by
Year
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ...
Nature 475 (7355), 226-230, 2011
13722011
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
GT Motz, SP Santoro, LP Wang, T Garrabrant, RR Lastra, IS Hagemann, ...
Nature medicine 20 (6), 607-615, 2014
9472014
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis
WT Hwang, SF Adams, E Tahirovic, IS Hagemann, G Coukos
Gynecologic oncology 124 (2), 192-198, 2012
6812012
Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus–unrelated head and neck cancer: a multicenter, phase II trial
R Uppaluri, KM Campbell, AM Egloff, P Zolkind, ZL Skidmore, ...
Clinical Cancer Research 26 (19), 5140-5152, 2020
2402020
Clinical next‐generation sequencing in patients with non–small cell lung cancer
IS Hagemann, S Devarakonda, CM Lockwood, DH Spencer, K Guebert, ...
Cancer 121 (4), 631-639, 2015
2262015
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor
E Lanitis, M Poussin, IS Hagemann, G Coukos, R Sandaltzopoulos, ...
Molecular Therapy 20 (3), 633-643, 2012
2182012
Validation of a next-generation sequencing assay for clinical molecular oncology
CE Cottrell, H Al-Kateb, AJ Bredemeyer, EJ Duncavage, DH Spencer, ...
The Journal of molecular diagnostics 16 (1), 89-105, 2014
1992014
High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models
JP Monaco, JE Tomaszewski, MD Feldman, I Hagemann, M Moradi, ...
Medical image analysis 14 (4), 617-629, 2010
1672010
Geometric Magnetic Frustration in Ba2Sn2Ga3ZnCr7O22: A Two-Dimensional Spinel Based Kagomé Lattice
IS Hagemann, Q Huang, XPA Gao, AP Ramirez, RJ Cava
Physical review letters 86 (5), 894-897, 2001
1592001
Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels
E Lanitis, D Dangaj, IS Hagemann, DG Song, A Best, R Sandaltzopoulos, ...
Plos one 7 (11), e49829, 2012
972012
T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides
KE Sufficool, CM Lockwood, HJ Abel, IS Hagemann, JA Schumacher, ...
Journal of the American Academy of Dermatology 73 (2), 228-236. e2, 2015
922015
Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).
R Uppaluri, P Zolkind, T Lin, B Nussenbaum, RS Jackson, J Rich, ...
Journal of Clinical Oncology 35 (15_suppl), 6012-6012, 2017
902017
Evaluation of ovarian cancer: initial application of coregistered photoacoustic tomography and US
S Nandy, A Mostafa, IS Hagemann, MA Powell, E Amidi, K Robinson, ...
Radiology 289 (3), 740-747, 2018
842018
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer
CX Ma, V Suman, MP Goetz, D Northfelt, ME Burkard, F Ademuyiwa, ...
Clinical Cancer Research 23 (22), 6823-6832, 2017
812017
Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity
X Zhang, S Kim, J Hundal, JM Herndon, S Li, AA Petti, SD Soysal, L Li, ...
Cancer immunology research 5 (7), 516-523, 2017
772017
Risk of occult malignancy in morcellated hysterectomy: a case series
IS Hagemann, AR Hagemann, VA LiVolsi, KT Montone, CS Chu
International journal of gynecological pathology 30 (5), 476-483, 2011
742011
Synthesis, structure and physical properties of Ru ferrites: BaMRu5O11 (M= Li and Cu) and BaM′2Ru4O11 (M′= Mn, Fe and Co)
ML Foo, Q Huang, JW Lynn, WL Lee, T Klimczuk, IS Hagemann, NP Ong, ...
Journal of Solid State Chemistry 179 (2), 563-572, 2006
742006
Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers
B Zhang, XY Xing, J Li, RF Lowdon, Y Zhou, N Lin, B Zhang, V Sundaram, ...
BMC genomics 15, 1-21, 2014
662014
The ovarian cancer chemokine landscape is conducive to homing of vaccine-primed and CD3/CD28–costimulated T cells prepared for adoptive therapy
E Zsiros, P Duttagupta, D Dangaj, H Li, R Frank, T Garrabrant, ...
Clinical Cancer Research 21 (12), 2840-2850, 2015
652015
Molecular testing in breast cancer: a guide to current practices
IS Hagemann
Archives of Pathology & Laboratory Medicine 140 (8), 815-824, 2016
632016
The system can't perform the operation now. Try again later.
Articles 1–20